Natixis
KURA icon

Natixis’s Kura Oncology KURA Stock Holding History

Natixis’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$30.4K Buy
+2,840
New +$31.8K ﹤0.01% 1040

Other funds holding KURA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Jupiter Asset Management
Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Natixis's KURA Position: Q3 2026 in Review

Natixis opened a new position in Kura Oncology (KURA) in Q3 2026: 2,840 shares worth $30.4K. The stake represents ﹤0.01% of the portfolio and ranks #1040 among its holdings.

108 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • Natixis held 2,840 shares of Kura Oncology worth $30.4K as of Q3 2026.
  • Kura Oncology was a new Natixis position in Q3 2026.
  • Kura Oncology made up ﹤0.01% of Natixis's portfolio in Q3 2026, its #1040 holding.
  • 108 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on Natixis's 13F filing for Q3 2026, filed 6 Nov 2026.